LINKPHCommodity Chemicals
Link Pharma Chem Ltd — Profit & Loss Statement
₹22.66
-13.42%
Link Pharma Chem Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -0.17 Cr | 0.10 Cr | — |
| Tax Rate For Calcs | 0.27 | 0.29 | 0.26 | 0.28 | — |
| Normalized EBITDA | 0.32 Cr | -95000.00 | 3.22 Cr | 3.62 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | -1.03 Cr | -1.36 Cr | 0.65 Cr | 1.88 Cr | — |
| Reconciled Depreciation | 0.94 Cr | 1.03 Cr | 0.92 Cr | 0.93 Cr | — |
| Reconciled Cost Of Revenue | 12.54 Cr | 16.68 Cr | 23.22 Cr | 38.30 Cr | — |
| EBITDA | 0.32 Cr | -95000.00 | 2.56 Cr | 3.96 Cr | — |
| EBIT | -0.63 Cr | -1.04 Cr | 1.64 Cr | 3.03 Cr | — |
| Net Interest Income | -0.78 Cr | -0.87 Cr | -0.73 Cr | -0.34 Cr | — |
| Interest Expense | 0.78 Cr | 0.87 Cr | 0.75 Cr | 0.41 Cr | — |
| Normalized Income | -1.03 Cr | -1.36 Cr | 1.14 Cr | 1.64 Cr | — |
| Net Income From Continuing And Discontinued Operation | -1.03 Cr | -1.36 Cr | 0.65 Cr | 1.88 Cr | — |
| Total Expenses | 26.25 Cr | 31.58 Cr | 36.57 Cr | 50.99 Cr | — |
| Diluted Average Shares | 0.44 Cr | 0.44 Cr | 0.44 Cr | 0.44 Cr | — |
| Basic Average Shares | 0.44 Cr | 0.44 Cr | 0.44 Cr | 0.44 Cr | — |
| Diluted EPS | -2.31 | -3.07 | 1.47 | 4.24 | — |
| Basic EPS | -2.31 | -3.07 | 1.47 | 4.24 | — |
| Diluted NI Availto Com Stockholders | -1.03 Cr | -1.36 Cr | 0.65 Cr | 1.88 Cr | — |
| Net Income Common Stockholders | -1.03 Cr | -1.36 Cr | 0.65 Cr | 1.88 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | -1.03 Cr | -1.36 Cr | 0.65 Cr | 1.88 Cr | — |
| Net Income Including Noncontrolling Interests | -1.03 Cr | -1.36 Cr | 0.65 Cr | 1.88 Cr | — |
| Net Income Continuous Operations | -1.03 Cr | -1.36 Cr | 0.65 Cr | 1.88 Cr | — |
| Tax Provision | -0.38 Cr | -0.55 Cr | 0.23 Cr | 0.74 Cr | — |
| Pretax Income | -1.40 Cr | -1.92 Cr | 0.89 Cr | 2.62 Cr | — |
| Other Non Operating Income Expenses | 0.19 Cr | 0.64 Cr | -0.15 Cr | 14000.00 | — |
| Net Non Operating Interest Income Expense | -0.78 Cr | -0.87 Cr | -0.73 Cr | -0.34 Cr | — |
| Interest Expense Non Operating | 0.78 Cr | 0.87 Cr | 0.75 Cr | 0.41 Cr | — |
| Operating Income | -0.81 Cr | -1.68 Cr | 2.19 Cr | 2.57 Cr | — |
| Operating Expense | 13.70 Cr | 14.90 Cr | 13.35 Cr | 12.69 Cr | — |
| Other Operating Expenses | 7.37 Cr | 8.35 Cr | 5.82 Cr | 4.94 Cr | — |
| Depreciation And Amortization In Income Statement | 0.94 Cr | 1.03 Cr | 0.92 Cr | 0.93 Cr | — |
| Depreciation Income Statement | 0.94 Cr | 1.03 Cr | 0.92 Cr | 0.93 Cr | — |
| Gross Profit | 12.89 Cr | 13.22 Cr | 15.54 Cr | 15.26 Cr | — |
| Cost Of Revenue | 12.54 Cr | 16.68 Cr | 23.22 Cr | 38.30 Cr | — |
| Total Revenue | 25.43 Cr | 29.90 Cr | 38.76 Cr | 53.56 Cr | — |
| Operating Revenue | 25.43 Cr | 29.90 Cr | 38.76 Cr | 53.56 Cr | — |
| Total Unusual Items | — | 0.56 Cr | -0.66 Cr | 0.34 Cr | -0.16 Cr |
| Total Unusual Items Excluding Goodwill | — | 0.56 Cr | -0.66 Cr | 0.34 Cr | -0.16 Cr |
| Interest Income | — | 0.05 Cr | 0.03 Cr | 0.11 Cr | 54000.00 |
| Rent Expense Supplemental | — | 0.06 Cr | 0.03 Cr | 0.04 Cr | 0.02 Cr |
| Special Income Charges | — | 0.06 Cr | -0.40 Cr | 0.12 Cr | -0.16 Cr |
| Other Special Charges | — | -0.08 Cr | — | -0.12 Cr | 0.16 Cr |
| Write Off | — | 0.02 Cr | 0.40 Cr | 0.00 | — |
| Total Other Finance Cost | — | 0.06 Cr | 87000.00 | 0.04 Cr | 0.02 Cr |
| Interest Income Non Operating | — | 0.05 Cr | 0.03 Cr | 0.11 Cr | 54000.00 |
| Selling General And Administration | — | 1.06 Cr | 0.87 Cr | 0.99 Cr | 0.98 Cr |
| Selling And Marketing Expense | — | 0.38 Cr | 0.18 Cr | 0.41 Cr | 0.34 Cr |
| General And Administrative Expense | — | 0.68 Cr | 0.68 Cr | 0.58 Cr | 0.65 Cr |
| Rent And Landing Fees | — | 0.06 Cr | 0.03 Cr | 0.04 Cr | 0.02 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Link Pharma Chem Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.